Crinetics Pharmaceuticals Inc <CRNX.O>: UBS cuts to neutral from buy; cuts target price to $85 from $55
CRNX•Related News
Commvault Systems Inc <CVLT.O>: Piper Sandler cuts to neutral from overweight
CVLT•
Nasdaq Trade Halt <LGHL.O> Volatility Trading Pause at 10:57 AM
LGHL•
AUTO FILE-Geely rides to Ford’s rescue
F•
Nasdaq Trade Halt Continues <QMMM.O> Reason Not Available at 10:57 AM
QMMM•
Sherwin-Williams Does Not Expect Broad-Based Demand Recovery In 2H26-Conf Call
SHW•